Consumer Discretionary • Catalog/Specialty Distribution
$153.79 ▼ -11.41
(-6.91%)
MKT CAP: $19.23B • VOL: 2.44M
52W L $97 52W H $166
CDW // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $22.42B | $21.00B | $21.38B |
| YoY Revenue Growth % | +6.8% | -1.8% | — |
| Gross Profit | $4.87B | $4.60B | — |
| Gross Margin % | 21.7% | 21.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.66B | $1.65B | $1.68B |
| Operating Margin % | 7.4% | 7.9% | 7.9% |
| Net Income (GAAP) | $1.07B | $1.08B | $1.10B |
| EBITDA (Normalized) | $1.75B | $1.75B | $2.45B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.21B | $1.28B | $1.60B |
| Capital Expenditures (CapEx) | $117.1M | $122.6M | $961.9M |
| Free Cash Flow (FCF) | $1.09B | $1.15B | $636.8M |
| FCF Margin % | 4.9% | 5.5% | 3.0% |
| Return on Invested Capital (ROIC %) | 19.8% | 17.5% | 8.6% |
| Cash & Short-Term Equivalents | $618.7M | $503.5M | — |
| Total Debt (Short + Long Term) | $4.62B | $5.61B | $6.00B |
| Total Stockholders' Equity | $2.61B | $2.35B | $12.31B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CDW.